Medicaid and CHIP Income Eligibility Limits for Pregnant Women as a Percent of the Federal Poverty Level
eligibility Medicaid CHIP
View the Latest: Pregnancy
Filter
-
-
The Latest on Medication Abortion Access: The Court Awaits the FDA Review
Quick TakeDespite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion. In the meantime, clinicians may continue to mail mifepristone to pregnant patients seeking abortions regardless of where they live.
-
Deaths and Health Care Issues in ICE Detention Centers Under the Second Trump Administration
Issue BriefThis brief provides an overview of deaths in ICE custody and detention centers under the Trump administration based on KFF analysis of ICE detainee death reporting and news releases and reviews recent reports of health care issues in detention centers.
-
Medicaid Postpartum Coverage Extension Tracker
Issue BriefThis page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
-
Early Prenatal Care Use Falls, Gaps Widen for Women of Color, CDC Data Show
Quick TakeWhile the exact reasons for the recent declines in early prenatal care use are not known, disparities in maternal and infant health reflect underlying inequities in insurance coverage, access to care, and social and economic factors.
-
KFF Health Tracking Poll: Knowledge and Views of Medication Abortion
Poll FindingThis KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.
-
Racial Disparities in Maternal and Infant Health: Current Status and Key Issues
Issue BriefThis brief includes data on pregnancy and birth outcomes by race and ethnicity, describes the underlying factors driving disparities, and discusses current policies affecting maternal and infant health disparities.
-
Examining Short-Term Limited-Duration Health Plans on the Eve of ACA Marketplace Open Enrollment
Issue BriefAs Marketplace Open Enrollment nears, policy changes could leave millions of people facing substantially higher premiums and coverage loss, which could lead more consumers to purchase less expensive and less comprehensive coverage through short-term health plans. KFF analyzes short-term health policies sold by nine large insurers in 36 states, examining premiums, cost sharing, covered benefits, and coverage limitations and comparing them to ACA Marketplace plans.
-
KFF Tracking Poll on Health Information and Trust: Tylenol-Autism Link and Vaccine Policies
Poll FindingFollowing the Trump administration’s warning last month that using acetaminophen – the active ingredient in Tylenol – during pregnancy can increase the risk of autism in children, very few adults say the claim about a causal relationship is “definitely true,” though much of the public is uncertain whether to believe it. Trust in the CDC to provide reliable vaccine information has fallen to a new low.
-
New KFF-Washington Post Poll Explores Parents’ Vaccine Attitudes, and Confusion Follows ACIP Meeting on Vaccine Recommendations – The Monitor
FeatureThis volume explores findings from the KFF-Washington Post Survey of Parents on views of childhood vaccines; how ACIP may have contributed to concerns about hepatitis B and COVID-19 vaccines; recent HHS warnings about alleged links between Tylenol use in pregnancy and autism; and AI-generated deepfakes impersonating doctors to sell products.